PACS Group
Operates skilled nursing and senior-living facilities through locally led, centrally supported teams.
Something off on this page? Send us feedback.
Profile
Operates skilled nursing facilities providing short-term transitional and long-term custodial care, with smaller assisted- and independent-living businesses. Growth comes from acquiring and locally operating facilities with centralized services; skilled nursing generates nearly all patient revenue, while Medicare and Medicaid are the largest payors.
Operates skilled nursing facilities that provide post-acute rehabilitation, higher-acuity short-term transitional care, and long-term custodial care, alongside a smaller portfolio of assisted- and independent-living communities. More than 300 facilities span the United States, and skilled nursing generates nearly all patient and resident service revenue.
Expands mainly by acquiring facilities, investing in clinical teams, equipment, and physical plants, and using PACS Services for technology and back-office support. Local administrators retain day-to-day operating authority while regional and central teams support integration, compliance, staffing, billing, and risk management.
Revenue is concentrated in Medicare and Medicaid reimbursement, while results depend on clinical staffing, hospital referrals, care quality, licensing, and program-participation compliance. Ongoing government investigations and material weaknesses in financial controls remain unresolved; most facilities operate under leases.
Company facts
Key statistics
Year to date +8.3% · Average volume (30d) 805.0K
Analysts
Ratings
Target range
Latest analyst notes
| Date | Firm | Action | Prior rating | Rating | Prior target | Target |
|---|---|---|---|---|---|---|
| Aug 6, 2026 | UBS | Reiterate | Buy | $57 | $60 | |
| Jul 8, 2026 | UBS | Reiterate | Buy | $42 | $57 | |
| May 18, 2026 | Truist Financial | Target | $40 | $52 | ||
| May 13, 2026 | Oppenheimer | Reiterate | Outperform | $40 | $48 | |
| Mar 2, 2026 | RBC Capital | Target | $47 | $52 |
Earnings
EPS
Revenue
History
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Next session |
|---|---|---|---|---|---|---|---|
| Aug 4, 2026Q2 FY26 | $0.54 | $0.63 | +17.3% | $1.41B | $1.43B | +1.0% | +1.85% |
| May 11, 2026Q1 FY26 | $0.42 | $0.50 | +19.0% | $1.36B | $1.42B | +4.1% | +28.56% |
| Feb 26, 2026Q4 FY25 | $0.48 | $0.43 | −10.4% | $1.38B | $1.36B | −1.7% | −12.38% |
| Nov 19, 2025Q3 FY25 | $0.45 | $0.32 | −28.9% | $1.11B | $1.34B | +21.0% | +55.32% |
Financial highlights
| 12 quarters | Q1 FY25 | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | |
|---|---|---|---|---|---|---|---|
| Revenue | $1.28B | $1.31B | $1.34B | $1.36B | $1.42B | $1.43B | |
| Gross profit | $253.4M | $288.4M | $298.3M | $223.6M | $232.4M | $338.5M | |
| Operating income | $48.1M | $80.5M | $86.3M | $94.7M | $120.0M | $109.3M | |
| Net income | $28.5M | $51.0M | $52.4M | $59.7M | $80.7M | $76.4M | |
| Diluted EPS | $0.17 | $0.31 | $0.32 | $0.38 | $0.50 | $0.47 | |
| Gross margin | 19.8% | 22.0% | 22.2% | 16.5% | 16.4% | 23.7% | |
| Operating margin | 3.8% | 6.1% | 6.4% | 7.0% | 8.5% | 7.7% |
Fiscal years (4-quarter sums)FY23 $3.11B · FY24 $4.15B · FY25 $5.29B
Revenue by product · Q2 FY26
Balance sheet, Jun 30, 2026Cash & short-term investments $164.5M · Total debt $3.25B · Total assets $5.66B · Shareholders' equity $1.11B
Dividends
No dividends on record.
Ownership
Institutions and insiders are filed separately and overlap, so together they can pass the whole company. No split is drawn from them.
Shares outstanding 158.34M · Float 47.80M · 30.2% free float
Top shareholders13F · 13D/G · Form 4
| Holder | Shares | % outstanding | Form | Filed |
|---|---|---|---|---|
| Jason Hulse Murray · director, 10 percent owner, officer: Co-Founder, CEO & Chairman | 54.69M | 34.54% | Form 4 | Aug 24, 2026 |
| Jason Hulse Murray | 54.63M | 35.20% | 13G | Feb 13, 2025 |
| Mark Hancock · director, 10 percent owner: | 53.82M | 33.99% | Form 4 | Aug 27, 2026 |
| Cohen & Steers, Inc. | 8.34M | 5.27% | 13F | Aug 14, 2026 |
| FMR LLC | 6.21M | 3.92% | 13F | Aug 13, 2026 |
Insider tradesForm 4
| Date | Insider | Role | Shares | Avg price |
|---|---|---|---|---|
| Aug 14, 2026 | Patrick Hugh Conway | director | −3,497 | $44.41 |
| Aug 21, 2026 | Jason Hulse Murray | director, 10 percent owner, officer: Co-Founder, CEO & Chairman | −59,244 | $43.90 |
| Aug 20, 2026 | Jason Hulse Murray | director, 10 percent owner, officer: Co-Founder, CEO & Chairman | −91,306 | $43.92 |
| Aug 19, 2026 | Jason Hulse Murray | director, 10 percent owner, officer: Co-Founder, CEO & Chairman | −84,717 | $44.26 |
| Aug 18, 2026 | Jason Hulse Murray | director, 10 percent owner, officer: Co-Founder, CEO & Chairman | −66,797 | $44.18 |
Peers
- The Ensign Group
Closest public peer in skilled nursing and senior living
- National HealthCare
Skilled nursing and senior-care operator across the continuum
- Brookdale Senior Living
National senior-living operator overlapping assisted care
- Encompass Health
Inpatient rehab substitute for higher-acuity post-acute cases
- The Pennant Group
Home health, hospice, and senior living post-acute peer
- Sonida Senior Living
Smaller listed senior-housing peer in assisted living
CompareAfter-hours close
| Company | Price | Change | |||||
|---|---|---|---|---|---|---|---|
| PACS Group | $42.60 | −0.46% | $6.77B | 25.6 | 17.2 | 1.2 | — |
| The Ensign Group | $172.98 | +0.01% | $10.08B | 27.1 | 21.2 | 1.8 | +17.3% |
| National HealthCare | $222.70 | +0.21% | $3.48B | 25.1 | — | 2.2 | +9.4% |
| Brookdale Senior Living | $11.60 | −1.11% | $2.80B | — | 482.1 | 0.9 | −11.6% |
| Encompass Health | $120.85 | 0.00% | $11.99B | 19.7 | 18.9 | 1.9 | +9.6% |
| The Pennant Group | $37.08 | +0.05% | $1.29B | 41.2 | 25.6 | 1.2 | +35.8% |
| Sonida Senior Living | $37.46 | −0.13% | $1.78B | — | — | 3.4 | +122.0% |
| Median | 26.1 | 23.4 | 1.9 | +13.5% |